1. NEOPLASIA REVIEW Fe A. Bartolome, MD, FPASMAP Department of Pathology Our Lady of Fatima University 2. Nomenclature Benign tumors Suffix “oma” generally indicates…

1. AMP v. MyriadAs an introduction to Patent LawSmith, Parsons & Summa www.smithparsons.com © Philip Summa 2014 2. Introduction to Biotech Dr. Todd Steck February 19,…

1. Personalized Risk Assessment andDecision Support for Breast Cancer PreventionElissa Ozanne, PhD Zehra Omer Karen Carlson, MD July 30, 2012 2. USPSTF recommendationsThe…

1. Case 7.1 Breast Cancer BY: Abdullatiff Sami AL-Rashed 1 2. Objectives 2 1. What Is Breast Cancer. 2. Types of Breast Cancer. 3. Etiology of breast cancer. 4. Risk factors.…

1. Cancer is the abnormal, uncontrollable , continuous replication of cells which will inevitably lead to the formation of a tumor. 2. Forms in the tissues of the breastSpreads…

Slide 1Detecting Breast Cancer using Thermal and Optical Data AngelaBenFunkeMarkNancy Slide 2 NCI Annual Report, Journal of the National Cancer Institute. Dec. 2, 2008 Slide…

Slide 1Belgian Breast Meeting 13-14 October 2006 Dr C. Sibille Centre de Génétique Humaine - U.C.L. - Cliniques Universitaires Saint-LUC Current Issues in Hereditary Breast…

1. DNA Patent Law 101: The Myriad Decision and its Impact on Patenting Genes © 2014 Michael A. Cicero Southern Polytechnic State U. EE 3903 – Introduction to BME April…

1 IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION IN RE: BRCA1- AND BRCA2- BASED HEREDITARY CANCER TEST PATENT LITIGATION THIS DOCUMENT RELATES TO:…

Slide 1 1 1 AIPLA Firm Logo American Intellectual Property Law Association CURRENT STATE OF 35 USC 101: “USPTO GUIDELINES ON PRODUCTS OF NATURE, LAWS OF NATURE, AND NATURAL…